Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Scientific Reports|October 30, 2023
The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expressionManman Deng, Jinshui Tan, Ziying Fan, et al.
Oncotarget|March 27, 2012
Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphomaChangping Li, Michael A Thompson, Archito T Tamayo, et al.
Journal of Autoimmunity|May 1, 2019
Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE)Baozhu Liu, Yong Gu, Shanshan Pei, et al.
Blood|October 5, 2010
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathwaysLan V Pham, Lingchen Fu, Archito T Tamayo, et al.
Blood|June 15, 2007
Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphomaHai-Jun Zhou, Lan V Pham, Archito T Tamayo, et al.
Journal of Hematology & Oncology|October 31, 2015
Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RCLan V Pham, Gary Lu, Archito T Tamayo, et al.
The Journal of Biological Chemistry|December 21, 2007
Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modificationLan V Pham, Hai-Jun Zhou, Yen-Chiu Lin-Lee, et al.
The Journal of Biological Chemistry|April 29, 2006
Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytesYen-Chiu Lin-Lee, Lan V Pham, Archito T Tamayo, et al.
The American Journal of Surgical Pathology|October 25, 2016
Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 PatientsZhihong Hu, L Jeffrey Medeiros, Zi Chen, et al.
Frontiers in Oncology|March 29, 2021
CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 RearrangementsDelin Yuan, Genhong Li, Lian Yu, et al.
Pageof 5